ADMA vs IT · P/E 22, rev $426.5M vs P/E 16, rev $6.27B
ADMA Biologics Inc (ADMA) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported ADMA revenue for 2024-12-31 was $426.5M. Net income was $197.7M. Revenue was up 65.2% from 2023-12-31 to 2024-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the ADMA and IT stock pages for the full models.
Not investment advice.